Email Christopher Clausen

NASDAQ:CTMX Investor Notice: Lawsuit Alleges Securities Laws Violations by CytomX Therapeutics, Inc

An investor, who purchased NASDAQ:CTMX share, filed a lawsuit over alleged Securities Laws violations by CytomX Therapeutics, Inc..

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy